Aligos Therapeutics, Inc. announced it raised $85 Million in an initial filing from an offering of $125 Million
Aligos Therapeutics, Inc. announced it raised $85 Million in an initial filing from an offering of $125 Million
01/16/20, 5:31 PM
Location
Money raised
$85 million
Industry
biotechnology
Company Info
Location
one corporate dr., 2nd floor
san francisco, california, united states
Additional Info
Company Mission:
To become a world leader in the development of targeted therapies for liver diseases and viral infections, including nonalcoholic steatohepatitis (NASH) and COVID-19.
Scientific Overview:
Aligos Therapeutics is engaged in the discovery and development of purpose-built, potentially best-in-class drug candidates that target clinically validated mechanisms of action in NASH and viral diseases.